Offer - Urjas Oil for just ₹ 1 X
Rovamek A is an allopathic medicine The correct dosage of Rovamek A depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Rovamek A is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rovamek A safe for pregnant women?
Rovamek A has many dangerous side effects in pregnant women. If you are pregnant, do not consume Rovamek A without medical advice.
Is the use of Rovamek A safe during breastfeeding?
Breastfeeding women can take Rovamek A as it bears very minor side effects for them.
What is the effect of Rovamek A on the Kidneys?
Kidney can be affected by Rovamek A. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Rovamek A on the Liver?
There may be an adverse effect on the liver after taking Rovamek A. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Rovamek A on the Heart?
Rovamek A may have mild side effects on the heart. Most people will never see any effect on the heart.
Rovamek A should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rovamek A unless your doctor advises you to do so -
Is this Rovamek A habit forming or addictive?
Forming a habit of Rovamek A has not been reported.
Interaction between Food and Rovamek A
Taking Rovamek A with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Rovamek A
Taking Rovamek A with alcohol can have severely harmful effects on your health.
Rovamek A is to be taken orally preferably after a light meal. Generally, this drug can be safely taken depending upon the age and condition of the person. However, please take Rovamek A as directed by the physician.
Yes, Rovamek A is used in the treatment of chest pain (angina pectoris prophylaxis). Angina is an ischemic chest pain which occurs due to coronary artery disease. However, it is best to consult your doctor about the right treatment for chest pain.
Yes, you can take Rovamek A for headache. The exact mechanism is not known. However, some researchers suggest that Rovamek A blocks the action of chemical messenger ( bradykinin) which is responsible for headache.
Rovamek A primarily relieves pain because it is an analgesic. It also reduces inflammations (swellings) arising due to injuries and infections in the body. Apart from being an analgesic, it works by preventing strokes and other heart-related disorders by, the blood and reducing thromboxane (a chemical) responsible for making the platelets sticky. Hence by this action, it prevents blood clots which further prevents strokes and heart blockages.
Yes, [medicine] can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650